Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.

Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 11:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 150 matching trials from the live ClinicalTrials.gov search.
Filters: Condition: Neurodevelopmental Outcomes Clear all
Completed Phase 4 Interventional

Promoting Positive Outcomes for Individuals With ASD: Linking Early Detection, Treatment, and Long-term Outcomes

NCT03333629
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Enhanced early detection
Behavioral
Lead sponsor
Drexel University
Other
Eligibility
16 Months to 58 Months
Enrollment
2,087 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2024
U.S. locations
3
States / cities
Sacramento, California • Storrs, Connecticut • Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Aug 16, 2024 · Synced Oct 25, 2026, 11:38 PM EDT
Completed No phase listed Observational Accepts healthy volunteers

Near-infrared Spectroscopy (NIRS) Neurodevelopmental Outcomes

NCT00464100
View directory record Official record
Conditions
Hypoplastic Left Heart Syndrome
Interventions
Not listed
Lead sponsor
Medical College of Wisconsin
Other
Eligibility
4 Years to 5 Years
Enrollment
48 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2006 – 2013
U.S. locations
1
States / cities
Milwaukee, Wisconsin
Source: ClinicalTrials.gov public record
Updated Aug 15, 2019 · Synced Oct 25, 2026, 11:38 PM EDT
Completed Not applicable Interventional

Improving Neurodevelopmental Outcomes in Children With Congenital Heart Disease: An Intervention Study

NCT03023644
View directory record Official record
Conditions
Congenital Heart Defect, Executive Function, Children, Neurodevelopmental Disorders, Working Memory, Infant Open Heart Surgery
Interventions
Cogmed Working Memory Training
Behavioral
Lead sponsor
Boston Children's Hospital
Other
Eligibility
7 Years to 12 Years
Enrollment
106 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2020
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Feb 1, 2021 · Synced Oct 25, 2026, 11:38 PM EDT
Completed Phase 4 Interventional

A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder

NCT00190931
View directory record Official record
Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
Atomoxetine Hydrochloride, placebo
Drug
Lead sponsor
Eli Lilly and Company
Industry
Eligibility
18 Years to 49 Years
Enrollment
400 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2003 – 2005
U.S. locations
1
States / cities
Columbia, Missouri
Source: ClinicalTrials.gov public record
Updated Jul 24, 2006 · Synced Oct 25, 2026, 11:38 PM EDT
Completed Not applicable Interventional

Neural and Behavioral Outcomes of Social Skills Groups in Children With Autism Spectrum Disorder (ASD)

NCT01190917
View directory record Official record
Conditions
Autism, Autism Spectrum Disorder
Interventions
Cognitive Behavioral Therapy (CBT), Play Therapy
Behavioral
Lead sponsor
Icahn School of Medicine at Mount Sinai
Other
Eligibility
8 Years to 11 Years
Enrollment
50 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2012
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Oct 2, 2012 · Synced Oct 25, 2026, 11:38 PM EDT
Completed No phase listed Observational Accepts healthy volunteers

Clinical Testing of a Real-Time Behavior Measurement Tool: Measuring Outcomes for CHAnge

NCT03229928
View directory record Official record
Conditions
Neurodevelopmental Disorders
Interventions
MOCHA
Device
Lead sponsor
University of North Carolina, Chapel Hill
Other
Eligibility
5 Years and older
Enrollment
10 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2017 – 2018
U.S. locations
1
States / cities
Chapel Hill, North Carolina
Source: ClinicalTrials.gov public record
Updated May 8, 2018 · Synced Oct 25, 2026, 11:38 PM EDT
Recruiting No phase listed Observational

Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure

NCT06026969
View directory record Official record
Conditions
Lyme Disease, Post-Treatment Lyme Disease, Chronic Lyme Disease, Tick-Borne Infections, Pregnancy Complications, Child Development
Interventions
Neurodevelopmental assessments and follow-up
Other
Lead sponsor
Children's National Research Institute
Other
Eligibility
18 Years and older
Enrollment
40 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2026
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Jun 16, 2026 · Synced Oct 25, 2026, 11:38 PM EDT
Completed Not applicable Interventional

Social and Communication Outcomes for Young Children With Autism

NCT00953095
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Joint Attention Intervention
Behavioral
Lead sponsor
Health Resources and Services Administration (HRSA)
Federal
Eligibility
24 Months to 60 Months
Enrollment
112 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2011
U.S. locations
5
States / cities
Los Angeles, California • Tallahassee, Florida • Baltimore, Maryland + 2 more
Source: ClinicalTrials.gov public record
Updated Sep 25, 2014 · Synced Oct 25, 2026, 11:38 PM EDT
Recruiting Not applicable Interventional

Digital Health Intervention for Children With ADHD

NCT06456372
View directory record Official record
Conditions
ADHD
Interventions
Digital Health Intervention Group
Behavioral
Lead sponsor
University of California, Riverside
Other
Eligibility
8 Years to 12 Years
Enrollment
60 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2027
U.S. locations
2
States / cities
Irvine, California • Riverside, California
Source: ClinicalTrials.gov public record
Updated Jan 28, 2026 · Synced Oct 25, 2026, 11:38 PM EDT
Not listed Not applicable Interventional

Supportive Outcomes Through Listening, Validation, and Empowerment

NCT06587594
View directory record Official record
Conditions
Autism Spectrum Disorder (ASD)
Interventions
Solution Focused Brief Therapy
Behavioral
Lead sponsor
University of Texas at Austin
Other
Eligibility
18 Years to 30 Years
Enrollment
5 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2025
U.S. locations
1
States / cities
Austin, Texas
Source: ClinicalTrials.gov public record
Updated Sep 19, 2024 · Synced Oct 25, 2026, 11:38 PM EDT
Completed Phase 1 Interventional

Outcomes In Children With Developmental Delay And Deafness

NCT01256229
View directory record Official record
Conditions
Deafness, Hearing Loss
Interventions
cochlear implantation, hearing aids
Device
Lead sponsor
Stanford University
Other
Eligibility
1 Day to 5 Years
Enrollment
303 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2016
U.S. locations
2
States / cities
Stanford, California • Houston, Texas
Source: ClinicalTrials.gov public record
Updated Nov 15, 2016 · Synced Oct 25, 2026, 11:38 PM EDT
Completed Not applicable Interventional

Growth Hormone Treatment of Children With HIV-Associated Growth Failure

NCT00006143
View directory record Official record
Conditions
HIV Infections
Interventions
Somatropin
Drug
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Eligibility
4 Years to 13 Years
Enrollment
102 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
Ends 2002
U.S. locations
18
States / cities
Phoenix, Arizona • Los Angeles, California • San Diego, California + 13 more
Source: ClinicalTrials.gov public record
Updated Nov 1, 2021 · Synced Oct 25, 2026, 11:38 PM EDT
Terminated Phase 1Phase 2 Interventional Results available

Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia

NCT04614974
View directory record Official record
Conditions
Laryngomalacia, Gastro Esophageal Reflux
Interventions
Famotidine, Speech Language Therapy
Drug · Other
Lead sponsor
Reema Padia
Other
Eligibility
0 Months to 6 Months
Enrollment
65 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020 – 2024
U.S. locations
1
States / cities
Pittsburgh, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Jul 20, 2025 · Synced Oct 25, 2026, 11:38 PM EDT
Completed Not applicable Interventional Results available

Umbilical Cord Milking in Non-Vigorous Infants Developmental Followup (MINVIFU)

NCT03621943
View directory record Official record
Conditions
Neurodevelopmental Abnormality
Interventions
Umbilical Cord Milking, Early Cord Clamping
Procedure
Lead sponsor
Sharp HealthCare
Other
Eligibility
22 Months to 26 Months
Enrollment
1,207 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2023
U.S. locations
7
States / cities
Davis, California • Loma Linda, California • San Diego, California + 3 more
Source: ClinicalTrials.gov public record
Updated Mar 27, 2025 · Synced Oct 25, 2026, 11:38 PM EDT
Completed No phase listed Observational

Extension for Community Healthcare Outcomes (ECHO) Autism Diagnostic Study in Primary Care Setting

NCT05223374
View directory record Official record
Conditions
Children18-72 Months With a Suspicion Autistic Disorder
Interventions
Canvas Dx
Device
Lead sponsor
Cognoa, Inc.
Industry
Eligibility
18 Months to 72 Months
Enrollment
110 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022 – 2024
U.S. locations
1
States / cities
Columbia, Missouri
Source: ClinicalTrials.gov public record
Updated Feb 8, 2024 · Synced Oct 25, 2026, 11:38 PM EDT
Terminated Not applicable Interventional

Cord Milking Impacts Neurodevelopmental Outcomes in Very Low Birth Weight Infants

NCT02987764
View directory record Official record
Conditions
Very Low Birth Weight Infant
Interventions
cord milking
Other
Lead sponsor
University of California, Los Angeles
Other
Eligibility
Up to 32 Weeks
Enrollment
5 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2016 – 2018
U.S. locations
1
States / cities
Los Angeles, California
Source: ClinicalTrials.gov public record
Updated Oct 15, 2018 · Synced Oct 25, 2026, 11:38 PM EDT
Completed Phase 1 Interventional

Impact of Competency-Based Training and Technical Assistance Employment Outcomes of Individuals With ID/DD

NCT06586827
View directory record Official record
Conditions
Intellectual Disability, Developmental Disability
Interventions
VCU-RRTC Online Course, Zoom Technical Assistance Sessions (6 total)
Other
Lead sponsor
Virginia Commonwealth University
Other
Eligibility
18 Years and older
Enrollment
60 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2025
U.S. locations
1
States / cities
Richmond, Virginia
Source: ClinicalTrials.gov public record
Updated Jul 31, 2025 · Synced Oct 25, 2026, 11:38 PM EDT
Withdrawn Not applicable Interventional

Telepsychiatry in Rural Youth

NCT01096953
View directory record Official record
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
Mental health care implemented by telepsychiatry, Face-to-face care
Behavioral
Lead sponsor
Oregon Health and Science University
Other
Eligibility
6 Years to 17 Years
Healthy volunteers
Healthy volunteers not accepted
Timeline
2010 – 2011
U.S. locations
1
States / cities
Roseburg, Oregon
Source: ClinicalTrials.gov public record
Updated Sep 11, 2019 · Synced Oct 25, 2026, 11:38 PM EDT
Completed Not applicable Interventional

Improving STEM Outcomes for Young Children With Language Learning Disabilities Via Telehealth

NCT04775199
View directory record Official record
Conditions
Language Development Disorders
Interventions
Language Intervention
Behavioral
Lead sponsor
Karla McGregor
Other
Eligibility
4 Years to 7 Years
Enrollment
32 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2023
U.S. locations
1
States / cities
Newark, Delaware
Source: ClinicalTrials.gov public record
Updated Aug 14, 2023 · Synced Oct 25, 2026, 11:38 PM EDT
Not listed Phase 1Phase 2 Interventional

Intervening Early With Neglected Children

NCT02093052
View directory record Official record
Conditions
Conduct Disorder, ADHD, Depression
Interventions
Attachment and Biobehavioral Catch-up, Developmental Education for Families
Behavioral
Lead sponsor
University of Delaware
Other
Eligibility
6 Years to 8 Years
Enrollment
220 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2005 – 2024
U.S. locations
1
States / cities
Newark, Delaware
Source: ClinicalTrials.gov public record
Updated Nov 17, 2020 · Synced Oct 25, 2026, 11:38 PM EDT
Completed Not applicable Interventional

Modulating Intensity and Dosage of Aphasia Scripts

NCT04138940
View directory record Official record
Conditions
Aphasia
Interventions
Script Training
Behavioral
Lead sponsor
Shirley Ryan AbilityLab
Other
Eligibility
21 Years and older
Enrollment
85 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020 – 2024
U.S. locations
1
States / cities
Chicago, Illinois
Source: ClinicalTrials.gov public record
Updated May 28, 2025 · Synced Oct 25, 2026, 11:38 PM EDT
Recruiting No phase listed Observational

Patterns of Neurodevelopmental Disorders

NCT06213090
View directory record Official record
Conditions
Neurodevelopmental Disorders, Autism Spectrum Disorder, Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infection, Pediatric Acute-Onset Neuropsychiatric Syndrome, Down Syndrome, Epilepsy, Mitochondrial Encephalomyopathies, Cerebral Folate Deficiency
Interventions
Not listed
Lead sponsor
Richard Frye
Other
Eligibility
Not listed
Enrollment
1,000 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2030
U.S. locations
1
States / cities
Phoenix, Arizona
Source: ClinicalTrials.gov public record
Updated Apr 16, 2026 · Synced Oct 25, 2026, 11:38 PM EDT
Not listed Phase 1 Interventional

Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth

NCT00491413
View directory record Official record
Conditions
Asphyxia
Interventions
epoetin
Drug
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Eligibility
Up to 6 Hours
Enrollment
15 participants
Healthy volunteers
Healthy volunteers not accepted
U.S. locations
1
States / cities
St. Petersburg, Florida
Source: ClinicalTrials.gov public record
Updated Jun 26, 2007 · Synced Oct 25, 2026, 11:38 PM EDT
Completed Phase 4 Interventional Accepts healthy volunteers Results available

Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in Children

NCT02712996
View directory record Official record
Conditions
Traumatic Brain Injury, Attention Deficit Disorder
Interventions
Lisdexamfetamine, Placebo
Drug
Lead sponsor
Vanderbilt University
Other
Eligibility
6 Years to 16 Years
Enrollment
20 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2017 – 2019
U.S. locations
1
States / cities
Nashville, Tennessee
Source: ClinicalTrials.gov public record
Updated Jul 13, 2020 · Synced Oct 25, 2026, 11:38 PM EDT